Zevra Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZVRA and other ETFs, options, and stocks.About ZVRA
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
ZVRA Key Statistics
Stock Snapshot
As of today, Zevra Therapeutics(ZVRA) shares are valued at $12.82. The company's market cap stands at 761.3M, with a P/E ratio of 13.38.
On 2026-09-08, Zevra Therapeutics(ZVRA) stock moved within a range of $12.19 to $12.90. With shares now at $12.82, the stock is trading +5.2% above its intraday low and -0.6% below the session's peak.
Trading volume for Zevra Therapeutics(ZVRA) stock has reached 699.1K, versus its average volume of 852.55K.
The stock's 52-week range extends from a low of $7.16 to a high of $15.04.
The stock's 52-week range extends from a low of $7.16 to a high of $15.04.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.